News
Translational Cancer Research (TCR) is going to publish monthly starting in September 2019!
Translational Cancer Research
2019;
8
(5)
:1655
.
(30 September 2019)
Editorial
Single nucleotide polymorphisms as the new predictors of therapy decisions in gastroesophageal junction and gastric adenocarcinoma?
Translational Cancer Research
2019;
8
(5)
:1656-1658
.
(30 September 2019)
The hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-Barr virus?
Translational Cancer Research
2019;
8
(5)
:1659-1662
.
(30 September 2019)
Original Article
Circular RNA SMARCA5 is overexpressed and promotes cell proliferation, migration as well as invasion while inhibits cell apoptosis in bladder cancer
Translational Cancer Research
2019;
8
(5)
:1663-1671
.
(30 September 2019)
Circ-ITCH correlates with less advanced tumor features as well as prolonged survival, and it inhibits cells proliferation but promotes apoptosis in non-small cell lung cancer
Translational Cancer Research
2019;
8
(5)
:1672-1679
.
(30 September 2019)
Inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma
Translational Cancer Research
2019;
8
(5)
:1680-1689
.
(30 September 2019)
Efficacy and safety of liposome-paclitaxel/liposome-paclitaxel combined with S-1 in 17 advanced gastric cancer patients with poor performance status
Translational Cancer Research
2019;
8
(5)
:1690-1698
.
(30 September 2019)
Serum oxidative stress is an independent prognostic marker in colorectal cancer
Translational Cancer Research
2019;
8
(5)
:1699-1708
.
(30 September 2019)
Effects of insulin-like growth factor binding protein 3 on cell growth and tumorigenesis in oral squamous cell carcinoma
Translational Cancer Research
2019;
8
(5)
:1709-1717
.
(30 September 2019)
miR-21 facilitates the diagnostic value of miR-138 for papillary thyroid cancer in formalin-fixed paraffin-embedded tissues
Translational Cancer Research
2019;
8
(5)
:1718-1726
.
(30 September 2019)
Prognostic values of preoperative albumin to globulin ratio for predicting clinical outcome in patients with high-grade gliomas
Translational Cancer Research
2019;
8
(5)
:1727-1733
.
(30 September 2019)
Efficacy analysis of endoscopic submucosal dissection in gastric adenocarcinoma of fundic gland type: five cases of more than 36 months of follow-up
Translational Cancer Research
2019;
8
(5)
:1734-1740
.
(30 September 2019)
Identifying pathological subtypes of non-small-cell lung cancer by using the radiomic features of 18F-fluorodeoxyglucose positron emission computed tomography
Translational Cancer Research
2019;
8
(5)
:1741-1749
.
(30 September 2019)
Partial penectomy or total penectomy for T1 and T2 squamous cell carcinoma of the penis?
Translational Cancer Research
2019;
8
(5)
:1750-1755
.
(30 September 2019)
KISS1 protein expression is associated with worse prognosis in osteosarcoma patients: a long-term follow-up study
Translational Cancer Research
2019;
8
(5)
:1756-1762
.
(30 September 2019)
MicroRNA let-7a inhibits proliferation of breast cancer cell by downregulating USP32 expression
Translational Cancer Research
2019;
8
(5)
:1763-1771
.
(30 September 2019)
PRDX6 promotes proliferation and induces chemo-resistance via peroxidase activity in Toledo diffuse large B-cell lymphoma cells
Translational Cancer Research
2019;
8
(5)
:1772-1781
.
(30 September 2019)
Wnt/β-catenin signaling pathway is involved in induction of apoptosis by oridonin in colon cancer COLO205 cells
Translational Cancer Research
2019;
8
(5)
:1782-1794
.
(30 September 2019)
Transradial access chemoembolization for hepatocellular carcinoma in comparation with transfemoral access
Translational Cancer Research
2019;
8
(5)
:1795-1805
.
(30 September 2019)
Integrin-α7 expression positively correlates with CD44 and CD133 expressions, and its high expression associates with advanced tumor features as well as poor survivals in non-small cell lung cancer patients
Translational Cancer Research
2019;
8
(5)
:1806-1816
.
(30 September 2019)
The high expression of lncRNA TUG1 correlates with progressive tumor condition and less satisfying survival profiles in prostate cancer patients
Translational Cancer Research
2019;
8
(5)
:1817-1825
.
(30 September 2019)
Prognostic significance of preoperative peripheral blood neutrophil to lymphocyte ratio (NLR) in lung sarcomatoid carcinoma
Translational Cancer Research
2019;
8
(5)
:1826-1833
.
(30 September 2019)
The influence of tumor heterogeneity on sensitivity of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIs
Translational Cancer Research
2019;
8
(5)
:1834-1844
.
(30 September 2019)
Mutational analysis of BRCA1 and BRCA2 in northwest Chinese breast cancer patients
Translational Cancer Research
2019;
8
(5)
:1845-1852
.
(30 September 2019)
Impact of the time from the completion of neoadjuvant chemotherapy to surgery on the outcomes of patients with gastric cancer
Translational Cancer Research
2019;
8
(5)
:1853-1862
.
(30 September 2019)
Effect of artesunate on apoptosis and autophagy in tamoxifen resistant breast cancer cells (TAM-R)
Translational Cancer Research
2019;
8
(5)
:1863-1872
.
(30 September 2019)
Silencing NEDD9 by lentivirus-delivered shRNA inhibits the growth of BxPC-3 cells in vitro and in vivo
Translational Cancer Research
2019;
8
(5)
:1873-1881
.
(30 September 2019)
Long-term changes in blood counts after intraoperative radiotherapy for breast cancer—single center experience and review of the literature
Translational Cancer Research
2019;
8
(5)
:1882-1903
.
(30 September 2019)
Proteomics score: a potential biomarker for the prediction of prognosis in non-small cell lung cancer
Translational Cancer Research
2019;
8
(5)
:1904-1917
.
(30 September 2019)
Clinicopathological features and prognostic analysis of signet ring cell gastric carcinoma: a population-based study
Translational Cancer Research
2019;
8
(5)
:1918-1930
.
(30 September 2019)
N6-methyladenosine could indirectly modulate translation in human cancer cells via cis-elements
Translational Cancer Research
2019;
8
(5)
:1931-1938
.
(30 September 2019)
Visceral fat measured by computed tomography and the risk of breast cancer
Translational Cancer Research
2019;
8
(5)
:1939-1949
.
(30 September 2019)
Comparison of liver function and safety in hepatocellular cancer patients treated with DEB-TACE and cTACE: a multi-center, retrospective cohort study
Translational Cancer Research
2019;
8
(5)
:1950-1964
.
(30 September 2019)
Enzalutamide alleviates anxiety and depression as well as improves quality of life compared to bicalutamide in metastatic castration-resistant prostate cancer patients: a cohort study
Translational Cancer Research
2019;
8
(5)
:1965-1974
.
(30 September 2019)
Knockdown of actin-like 8 inhibits cell proliferation by regulating FOXM1, STMN1, PLK1, and BIRC5 in lung adenocarcinoma A549 cells
Translational Cancer Research
2019;
8
(5)
:1975-1984
.
(30 September 2019)
DNA hypermethylation of MAL gene may act as an independent predictor of favorable prognosis in patients with colorectal cancer
Translational Cancer Research
2019;
8
(5)
:1985-1996
.
(30 September 2019)
Prazosin inhibits the growth and mobility of osteosarcoma cells
Translational Cancer Research
2019;
8
(5)
:1997-2004
.
(30 September 2019)
Rutin induces apoptosis via P53 up-regulation in human glioma CHME cells
Translational Cancer Research
2019;
8
(5)
:2005-2013
.
(30 September 2019)
Prognostic factors for breast cancer squamous cell carcinoma and nomogram development for prediction: population-based research
Translational Cancer Research
2019;
8
(5)
:2014-2023
.
(30 September 2019)
DNA hypermethylation of the promoter attenuates forkhead box protein 3 (FOXP3) expression in hepatocellular carcinoma cells
Translational Cancer Research
2019;
8
(5)
:2024-2031
.
(30 September 2019)
MicroRNA-204-3p modulates epithelial-mesenchymal transition by targeting paired box gene 2 in human melanoma A-375 cells
Translational Cancer Research
2019;
8
(5)
:2032-2043
.
(30 September 2019)
SE translation mRNA overexpression: a potential prognostic predictor in breast cancer
Translational Cancer Research
2019;
8
(5)
:2044-2052
.
(30 September 2019)
The value of preoperative lymphocytes-to-monocytes ratio in predicting lymph node metastasis in gastric cancer
Translational Cancer Research
2019;
8
(5)
:2053-2058
.
(30 September 2019)
PRC1 promotes cell proliferation and cell cycle progression by regulating p21/p27-pRB family molecules and FAK-paxillin pathway in non-small cell lung cancer
Translational Cancer Research
2019;
8
(5)
:2059-2072
.
(30 September 2019)
Comparison of perioperative characteristics and prognostic performance in patients with pulmonary lobectomy in early or later period after percutaneous coronary intervention
Translational Cancer Research
2019;
8
(5)
:2073-2078
.
(30 September 2019)
Melatonin enhances arsenic trioxide-induced cytotoxicity by modulating autophagy in an acute promyelocytic leukemia cell line
Translational Cancer Research
2019;
8
(5)
:2079-2088
.
(30 September 2019)
Systemic immune-inflammation index as a prognostic marker in patients with newly diagnosed metastatic nasopharyngeal carcinoma: a propensity score-matched study
Translational Cancer Research
2019;
8
(5)
:2089-2098
.
(30 September 2019)
Higher single dose of bortezomib plus thalidomide and dexamethasone is a promising therapy for newly diagnosed multiple myeloma
Translational Cancer Research
2019;
8
(5)
:2099-2106
.
(30 September 2019)
Detection of circulating tumor cells (CTCs) in cerebrospinal fluid of a patient with HER2-overexpressing gastric cancer and single cell analysis of intra-patient heterogeneity of CTCs
Translational Cancer Research
2019;
8
(5)
:2107-2112
.
(30 September 2019)
Nucleolar spindle associated protein 1 (NUSAP1) facilitates proliferation of hepatocellular carcinoma cells
Translational Cancer Research
2019;
8
(5)
:2113-2120
.
(30 September 2019)
Increased number of mast cells in the bone marrow of chronic myeloid leukemia may herald the pending myeloid transformation—the mast cell is an indicator of myeloid transformation
Translational Cancer Research
2019;
8
(5)
:2121-2129
.
(30 September 2019)
Anticancer effect of the traditional Chinese medicine herb Maytenus compound via the EGFR/PI3K/AKT/GSK3β pathway
Translational Cancer Research
2019;
8
(5)
:2130-2140
.
(30 September 2019)
LncRNA SNHG1 upregulates ROCK2 to reduce cisplatin sensitivity of NSCLC cells by targeting miR-101-3p
Translational Cancer Research
2019;
8
(5)
:2141-2150
.
(30 September 2019)
Impact of apatinib in combination with osimertinib on EGFR T790M-positive lung adenocarcinoma
Translational Cancer Research
2019;
8
(5)
:2151-2163
.
(30 September 2019)
Clinic-pathologic features and gene fusion pattern of ALK and ROS1 in non-small cell lung cancer show association with household coal combustion
Translational Cancer Research
2019;
8
(5)
:2164-2174
.
(30 September 2019)
Bioinformatic analysis of long non-coding RNA-associated competing endogenous RNA network in adrenocortical carcinoma
Translational Cancer Research
2019;
8
(5)
:2175-2186
.
(30 September 2019)
Brief Report
Rare GCC2-ALK fusion G13:A20 detected by next generation sequencing in non-small cell lung cancer patients and treatment response
Translational Cancer Research
2019;
8
(5)
:2187-2191
.
(30 September 2019)
Review Article
The functions of long non-coding RNAs in colorectal cancer
Translational Cancer Research
2019;
8
(5)
:2192-2204
.
(30 September 2019)
Immunomodulatory effects of intestinal lung axis microecology and other factors on the prognosis of advanced non-small cell lung cancer
Translational Cancer Research
2019;
8
(5)
:2205-2210
.
(30 September 2019)
Case Report
Aggressive fibromatosis-associated with papillary thyroid cancer: two cases and a brief review
Translational Cancer Research
2019;
8
(5)
:2211-2215
.
(30 September 2019)
Letter to the Editor
Androgen deprivation therapy in high risk prostate cancer
Translational Cancer Research
2019;
8
(5)
:2216-2217
.
(30 September 2019)
